BioTech, Health Policy and Study - Connected Health Pulse

Income Inequality is Fostering Mis-Trust, the Edelman 2020 Trust Barometer Observes

Health Populi

JANUARY 22, 2020

Together, these three factors erode workers’ confidence in jobs and their personal household economies and financial health. The second chart comes from the study, quantifying global citizens’ trust levels by industry sector since 2012.

BioTech

BioTech Primary Care Public Health Mental health

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

MARCH 11, 2021

Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics]. health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act.

Health Policy

Health Policy Medicare Pharmaceuticals Life Science

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

JUNE 24, 2021

We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models.

BioTech

BioTech Pharmaceuticals Public Health Telehealth

Will Technology Cure Americans’ Health Care System Ills? Considering Google and Ascension Health’s Data Deal

Health Populi

NOVEMBER 12, 2019

Note that hospitals garnered only about one-half of people in this study, and pharma and health plans fell to one-third of Americans’ responses to the question. health care. Now check out the third chart, which is a summary of the Edelman Trust Barometer for 2019 noting Americans’ trust in various industries.

BioTech

BioTech Medical Billing HIPAA Health Information

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

JANUARY 18, 2019

As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.

BioTech

BioTech Medicare Medical Billing Patient Experience

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

MAY 4, 2023

IQVIA’s national prescription data revealed that prescriptions for mental health drugs grew 8% since 2019 — with a 33% rise among girls under 19. There is another data point in the study on women’s health and prescriptions — for ADHD drugs.

Public Health

Public Health Mental health Life Science Telehealth

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

OCTOBER 28, 2019

84% of Americans told the Foundation that they were concerned about how much health care costs will affect them in the future, with 42% of patients saying they couldn’t afford to pay over $500 for an unexpected medical bill. Hospital costs contribute to rising medical costs to 49% of health consumers. Exacerbating U.S.

Pharmaceuticals

Pharmaceuticals Medical Billing Medicare Mental health

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

JULY 1, 2019

For more color, read Jane’s April 2008 report, “The Wisdom of Patients,” where she wrote about PLM in its start-up phase (see section on page 20 entitled “ An Ongoing, Live Outcomes Study ”). When this occurred, it didn’t cause more than a ripple of interest outside biotech. But the U.S. citizens’ personal data.

Pharmaceuticals

Pharmaceuticals HIPAA BioTech Patient Experience

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

MAY 8, 2019

As the second chart details, adherence among patients enrolled in Medicare Part D prescription drug coverage (the green bar) had the highest levels across the three payment sources studied and in all U.S.

Medicare

Medicare BioTech Pharmaceuticals Mental health

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

FEBRUARY 22, 2021

The study was written up by Beth Snyder Bulik in FiercePharma. Surprising, because technology [and health] underpin virtually all of the fastest-growing brands in 2020, shown in the second chart from Morning Consult’s study of U.S. Among the top 20 in this study were two pharma brands — Pfizer and AstraZeneca.

Life Science

Life Science Pharmaceuticals Public Health BioTech

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

JUNE 18, 2020

By demographics, more women than men are concerned about rising costs for the three health care spending categories the survey studied: drug prices, insurance premiums, and healthcare costs (medical care services spending). A majority of people across political party share this concern: overall, 88% of U.S. 84% of Republicans.

BioTech

BioTech Medicare Life Science Telehealth

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Health Populi

AUGUST 16, 2021

There is one health care public policy issue that unites U.S. In this study, the researchers identified the following costs by stakeholder: For patients, out-of-pocket expenses, including payments for deductibles, copayments, and coinsurance amounts. Health Populi’s Hot Points: While U.S.

Pharmaceuticals

Pharmaceuticals Telehealth BioTech Mental health

What Do Democrats and Republicans Agree On? Allowing Government & Business to Negotiate Lower Rx Prices

Health Populi

JUNE 3, 2021

Health Populi’s Hot Points: The last chart from the study (Figure 8) underscores the universality of the finding that lowering the price of prescription drugs is one of the very few issues in the U.S. 65% of Independents and. 57% of Republicans. that bring voters together.

Medicare

Medicare Life Science BioTech Pharmaceuticals

Two-Thirds of Americans Say Healthcare Doesn’t Work Well, in RealClear Politics Poll

Health Populi

MAY 19, 2019

.” Health Populi’s Hot Points: RealClear asked people to consult their forecasting tea leaves to consider which industries and organizations would improve the quality of health care for Americans 20 years into the future. That’s an interesting conundrum to consider.

Life Science

Life Science BioTech Medicare Medical Billing

Connected Health Pulse

Income Inequality is Fostering Mis-Trust, the Edelman 2020 Trust Barometer Observes

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Trending Sources

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Will Technology Cure Americans’ Health Care System Ills? Considering Google and Ascension Health’s Data Deal

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

What Do Democrats and Republicans Agree On? Allowing Government & Business to Negotiate Lower Rx Prices

Two-Thirds of Americans Say Healthcare Doesn’t Work Well, in RealClear Politics Poll

Stay Connected